Menopause or climacteric, just a semantic discussion or has it clinical implications?

References

• http://www.imsociety.org/cams.php. Accessed 08/04/2013
   Google Scholar
• http://www.ncbi.nlm.nih.gov/pubmed?term=menopausal%20Sympams. Accessed 08/04/2013
   Google Scholar
• http://www.ncbi.nlm.nih.gov/pubmed?term=Climacteric%20Sympams. Accessed 08/04/2013
   Google Scholar
• http://etimologias.dechile.net/?menopause. Accessed 08/04/2013
   Google Scholar
• http://www.imsociety.org/menopause_terminology.php. Accessed 08/04/2013
   Google Scholar
• http://www.menopause.org/for-women/menopause-gthesary. Accessed 08/04/2013
   Google Scholar
• http://etimologias.dechile.net/?climactery. Accessed 08/04/2013
   Google Scholar
• Harlow SD, Gass M, Hall JE, et al. Executive Summary: Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Climacteric 2012;15:105–14
   PubMed Web of Science ®Google Scholar
• Treloar AE. Menstrual cyclicity and the pre-menopause. Maturitas 1981;3:249–64
   PubMed Web of Science ®Google Scholar
• Ahmed Ebbiary NA, Lenan EA, Cooke ID. Hypothalamic- pituitary ageing: progressive increase in FSH and LH concentrations throughout the reproductive life in regularly menstruating women. Clin Endocrinol (Oxf) 1994;41:199–206
   PubMed Web of Science ®Google Scholar
• Randolph JF Jr, Zheng H, Sowers MR, et al. Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J Clin Endocrinol Metab 2011;96:746–54
   PubMed Web of Science ®Google Scholar
• Burger HG, Hale GE, Dennerstein L, Robertson DM. Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause 2008;15:603–12
   PubMed Web of Science ®Google Scholar
• Kaori I, Ayako T, Kazuhiro A, et al. Role of antimüllerian hormone as to biomarker of the menopausal transition. Menopause 2013;20:235–9
   Google Scholar
• NIH State of the Science Conference. Statement on management of menopause related symptoms. NIH Consens State Sci Statements 2005;22:1–38
   Google Scholar
• Blümel JE, Tacla X, Brandt A, Gramegna G, Estartus A. Knowledge and beliefs of the effect of menopause and estrogenic therapy on health. Study in women attending the Barros Luco-Trudeau Hospital.. Rev Chil Obstet Ginecol 1994;59: 10–16
   PubMedGoogle Scholar
• Avis NE, Stellaa R, Crawford S, et al. Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 2001;52:345–56
   PubMed Web of Science ®Google Scholar
• Kapur P, Sinha B, Pereira BM. Measuring climacteric symptoms and age at natural menopause in an Indian population using the Greene Climacteric Scale. Menopause 2009;16:378–84
   PubMed Web of Science ®Google Scholar
• Ishizuka B, Kudo Y, Tango T. Cross-sectional community survey of menopause symptoms among Japanese women. Maturitas 2008;61:260–7
   PubMed Web of Science ®Google Scholar
• Hauser GA, Huber IC, Keller PJ, Lauritzen C, Schneider HP. Evaluation of climacteric symptoms (Menopause Rating Scale). Zentralbl Gynakol 1994;116:16–23
   PubMedGoogle Scholar
• Hauser GA. A new rating scale for the climacteric syndrome (Menopause Rating Scale (MRS). Schweiz Med Wochenschr 1997;127:122–7
   PubMedGoogle Scholar
• Blümel JE, Chedraui P, Baron G, et al.; Collaborative Group for Research of the Climacteric in Latin America (REDLINC). Menopausal symptoms appear before the menopause and persist 5 years beyond: detailed analysis of two multinational studies. Climacteric 2012;15:542–51
   PubMed Web of Science ®Google Scholar
• Jokinen K, Rautava P, Mäkinen J, Ojanlatva A, Sundell J, Helenius H. Experience of climacteric symptoms among 42–46 and 52–56-year-old women. Maturitas 2003;46:199–205
   PubMed Web of Science ®Google Scholar
• Hardy R, Kuh D. Change in psychological and vasomotor symptom reporting during the menopause. Soc Sci Med 2002; 55:1975–88
   PubMed Web of Science ®Google Scholar
• Vanwesenbeeck I, Vennix P, van of Wiel H. Menopausal symptoms: associations with menopausal status and psychosocial facts. J Psychosom Obstet Gynaecol 2001;22:149–58
   PubMed Web of Science ®Google Scholar
• Blümel JE, Castelo-Branco C, Cancelo MJ, et al. Relationship between psychological complaints and vasomotor symptoms during climacteric. Maturitas 2004;49:205–10.
   PubMed Web of Science ®Google Scholar
• McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas 2008;61:4–16
   PubMed Web of Science ®Google Scholar
• Nikolopoulou A, Kadoglou NP. Obesity and metabolic syndrome as related to cardiovascular disease. Exp Rev Cardiovasc Ther 2012;10:933–9
   PubMedGoogle Scholar
• Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003–2006. Natl Health Stat Rep 2009;13:1–7
   PubMedGoogle Scholar
• Wissler RW, Strong JP, PDAY Research Group. Risk facts and progression of atherosclerosis in youth. Am J Pathol 1998; 153:1023–33
   PubMed Web of Science ®Google Scholar
• Blümel JE, Castelo-Branco C, Sanjuán A, et al. A simplified method to quantitate atherosclerosis in the rabbit aorta. Maturitas 2001;39:265–71
   PubMed Web of Science ®Google Scholar
• Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: meta-analysis. Menopause 2006;13:265–79
   PubMed Web of Science ®Google Scholar
• Rivera CM, Grossardt BR, Rhodes DJ, et al. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause 2009;16:15–23
   PubMed Web of Science ®Google Scholar
• Simoncini T. Mechanisms of action of estrogen receptors in vascular cells: relevance for menopause and aging. Climacteric 2009;12(Suppl 1): 6–11
   PubMedGoogle Scholar
• Williams JK, Shively CA, Clarkson TB. Determinants of coronary artery reactivity in premenopausal female cynomologus monkeys with diet-induced atherosclerosis. Circulation 1994;90:983–7
   PubMed Web of Science ®Google Scholar
• Tani A, Yasui T, Matsui S, et al. Different circulating levels of monocyte chemoattractant protein-1 and interleukin-8 during the menopausal transition. Cytakine 2013;62:86–90
   Google Scholar
• Bechlioulis A, Kalantaridou SN, Naka KK, et al. Endothelial function, but not carotid intima-media thickness, is affected early in menopause and is associated with severity of hot flushes. J Clin Endocrinol Metab 2010;95:1199–206
   PubMed Web of Science ®Google Scholar
• Hodis HN Mack WJ. Hormone replacement therapy and the association with coronary heart disease and overall mortality: Clinical application of the timing hypothesis. J Steroid Biochem Mol Biol 2013 Jul 9. Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Albright F, Bloomberg E, Smith P. Postmenopausal osteoporosis. Trans Assoc Am Physicians 1940;55:298–305
   Google Scholar
• Stevenson JC, Lees B, Devenport M, Cust MP, Ganger KF. Determinants of bone density in normal women: risk facts for future osteoporosis?. BMJ 1989; 298:924–8
   PubMed Web of Science ®Google Scholar
• Hoshino H, Kushida K, Takahashi M, et al. Changes in levels of biochemical markers and ultrasound indices of os calcis across the menopausal transition. Osteoporos Int 2000;11: 128–33
   PubMed Web of Science ®Google Scholar
• Versi E, Harvey MA, Cardozo L, Brincat M, Studd JW. Urogenital prolapse and atrophy at menopause: prevalence study. Int Urogynecol J Pelvic Floor Dysfunct 2001;12:107–10
   PubMed Web of Science ®Google Scholar
• Royer M,Castelo-Branco C,Blümel JE, et al. Collaborative Group for Research of the Climacteric in Latin America. The US National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women. Climacteric 2007; 10:164–70
   PubMed Web of Science ®Google Scholar
• International Menopause Society Writing Group. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric 2011; 14:302–20
   PubMed Web of Science ®Google Scholar
• North American Menopause Society. The 2012 hormone therapy position statement of The North American Menopause Society. Menopause 2012;19:257–71
   PubMed Web of Science ®Google Scholar
• Studd J, Panay N. Are oestrogens useful for the treatment of depression in women?. Best Pract Res Clin Obstet Gynaecol 2009;23:63–71
   PubMed Web of Science ®Google Scholar
• Slater CC, Hodis HN, Mack WJ, Shoupe D, Paulson RJ, Stanczyk FZ. Markedly elevated levels of estrone sulfate after long-term oral, but not transdermal, administration of estradiol in postmenopausal women. Menopause 2001;8:200–3
   PubMed Web of Science ®Google Scholar
• Brown T, Avenell A, Edmunds LD, et al. Systematic review of long-term lifestyle interventions to prevent weight gain and morbidity in adults. Obes Rev 2009;10:627–38
   PubMed Web of Science ®Google Scholar
• Babatunde OO, Forsyth JJ, Gidlow CJ. A meta-analysis of brief high-impact exercises for enhancing bone health in premenopausal women. Osteoporos Int 2012;23:109–19
   PubMed Web of Science ®Google Scholar
• Cummings SR, Tice JA, Bauer S, et al. Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst 2009;101:384–98
   PubMed Web of Science ®Google Scholar
• Greendale GA, Gold EB. Lifestyle facts: are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy?. Am J Med 2005;118(Suppl 12B): 148–54
   PubMedGoogle Scholar
• Kroenke CH, Caan BJ, Stefanick ML, et al. Effects of two dietary intervention and weight change on vasomotor symptoms in the Women’s Health Initiative. Menopause 2012;19:980–8
   PubMed Web of Science ®Google Scholar
• Gold EB, Flatt SW, Pierce JP, et al. Dietary facts and vasomotor symptoms in breast cancer survivors: the WHEL Study. Menopause 2006;13:423–33
   PubMed Web of Science ®Google Scholar